Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation

被引:58
作者
Belichenko, Nadia P. [1 ]
Belichenko, Pavel V. [1 ]
Mobley, William C. [1 ]
机构
[1] Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
关键词
Rett syndrome; MeCP2; Mouse models; Brain; Motor cortex; Spines; Morphometry; RETT-SYNDROME; MOUSE MODEL; CLINICAL PECULIARITIES; AXON GUIDANCE; EXPRESSION; NEUROTROPHINS; TRANSCRIPTION; MORPHOLOGY; DISORDERS;
D O I
10.1016/j.nbd.2008.12.016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the gene MECP2, encoding methyl-CpG-binding protein 2 (MeCP2). Few studies have explored dendritic morphology phenotypes in mouse models of RTT and none have determined whether these phenotypes in affected females are cell autonomous or nonautonomous. Using confocal microscopy analysis we have examined the structure of dendrites and spines in the motor cortex of wild-type (WT) and Mecp2-mutant mice expressing green fluorescent protein (GFP). In Mecp2 GFP female mice age 6-7 months we found significant decreases in the density of spines, width of dendrites, size of spine heads, while increases were found in the length of spine necks, dendritic irregularities, spineless spots, and long spines. We show for the first time that a lower density of spines and smaller spine head area are phenotypes that distinguish MeCP2+ from MeCP2- dendrites in female Mecp2 GFP mice. In Mecp2 GFP male mice at three weeks of age, we found reduced spine density, thinner apical oblique dendrites and increased dendritic irregularities and long spines. Significantly, the changes affected both MeCP2- and MeCP2+ neurons, pointing to the ability of MeCP2- to impact the structure of MeCP2+ neurons. Our findings are evidence that MeCP2 deficiency results in both cell autonomous and nonautonomous changes. Published by Elsevier Inc.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 35 条
  • [1] Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
    Amir, RE
    Van den Veyver, IB
    Wan, M
    Tran, CQ
    Francke, U
    Zoghbi, HY
    [J]. NATURE GENETICS, 1999, 23 (02) : 185 - 188
  • [2] SELECTIVE DENDRITIC ALTERATIONS IN THE CORTEX OF RETT-SYNDROME
    ARMSTRONG, D
    DUNN, JK
    ANTALFFY, B
    TRIVEDI, R
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (02) : 195 - 201
  • [3] Neuropathology of Rett syndrome
    Armstrong, DD
    [J]. JOURNAL OF CHILD NEUROLOGY, 2005, 20 (09) : 747 - 753
  • [4] ARMSTRONG DD, 1992, BRAIN DEV S, pS89
  • [5] MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function
    Barbosa, Ana C.
    Kim, Mi-Sung
    Ertunc, Mert
    Adachi, Megumi
    Nelson, Erika D.
    McAnally, John
    Richardson, James A.
    Kavalali, Ege T.
    Monteggia, Lisa M.
    Bassel-Duby, Rhonda
    Olson, Eric N.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (27) : 9391 - 9396
  • [6] Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome
    Belichenko, Nadia P.
    Belichenko, Pavel V.
    Li, Hong Hua
    Mobley, William C.
    Francke, Uta
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2008, 508 (01) : 184 - 195
  • [7] RETT-SYNDROME - 3-D CONFOCAL MICROSCOPY OF CORTICAL PYRAMIDAL DENDRITES AND AFFERENTS
    BELICHENKO, PV
    OLDFORS, A
    HAGBERG, B
    DAHLSTROM, A
    [J]. NEUROREPORT, 1994, 5 (12) : 1509 - 1513
  • [8] Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome
    Belichenko, PV
    Masliah, E
    Kleschevnikov, AM
    Villar, AJ
    Epstein, CJ
    Salehi, A
    Mobley, WC
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 480 (03) : 281 - 298
  • [9] Morphological study of neocortical areas in Rett syndrome
    Belichenko, PV
    Hagberg, B
    Dahlstrom, A
    [J]. ACTA NEUROPATHOLOGICA, 1997, 93 (01) : 50 - 61
  • [10] BELILES KE, 1995, MED PSYCH P, V3, P1